Guardian Pharmacy Services Reports Q3 Revenue of $377.4 Million and Net Income of $9.6 Million

Reuters
2025/11/11
<a href="https://laohu8.com/S/GRDN">Guardian Pharmacy</a> Services Reports Q3 Revenue of $377.4 Million and Net Income of $9.6 Million

Guardian Pharmacy Services Inc. reported third quarter 2025 financial results with revenue of $377.4 million, a 20% increase year-over-year. Adjusted EBITDA was $27.3 million, up from $23.0 million in the prior year period. Net income for the quarter was $9.6 million, compared to a net loss of $105.8 million in the same period last year, which included significant one-time share-based compensation expenses. Diluted earnings per share were $0.15, with adjusted EPS at $0.25. Cash and cash equivalents totaled $36.5 million at quarter-end with no long-term debt outstanding. The company raised its full-year 2025 guidance, now expecting revenue between $1.43 billion and $1.45 billion, and adjusted EBITDA between $104.0 million and $106.0 million. During the quarter, Guardian acquired Managed Healthcare Pharmacy, expanding its presence into Oregon and the Pacific Northwest. Residents served reached approximately 204,000, up 13% year-over-year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardian Pharmacy Services Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251110962786) on November 10, 2025, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10